Hair Growth Treatment

Q3 2021 New Companies: AddPharma, Novaliq, and Rizn

August 31, 2021 /

This article covers a few companies not previously discussed online and recent happenings in hair growth related news. AddPharma of Korea Where else would new hair growth medicine be coming out of but Korea? In the case of AddPharma, it’s a mixture of “old and new”, but we’ll take it. AddPharma is a pharmaceutical company…

Read More

Alopecia Areata Treatment Pipeline 2023

August 6, 2021 /

In this article we will cover the most prominent therapeutic candidates in the alopecia areata treatment industry in 2023. Frontrunners To Market In June 2022,  Eli Lilly/Incyte received the FDA’s first ever approval for a systemic treatment for alopecia areata with their drug Olumiant. Alopecia areata, an auto-immune disorder which results in patchy and sometimes…

Read More

David Sinclair Is Working On Hair Regeneration

June 26, 2021 /

Perhaps the world’s most famous aging researcher, Dr. David Sinclair of Harvard University, recently revealed that his lab is working on an advanced method for hair restoration. The Sinclair Lab at  Harvard Medical School Hair Growth Research Located in Boston, MA, The Sinclair Lab conducts cutting-edge research on the mechanisms of biological aging. The laboratory’s…

Read More

Turn Biotechnologies: mRNA Hair Growth Therapy

June 15, 2021 /

Today, I am pleased to introduce yet another company entering the hair growth treatment industry, Turn Biotechnologies. The company is creating therapies which restore human cells to a more youthful state and has a program targeting skin and hair. Turn Biotechnologies is one of the latest companies to make waves in the anti-aging/aging-reversal sector. The…

Read More

TechnoDerma Medicines Enters Clinical Trial & More

May 24, 2021 /

This article continues the recent trend of new company announcements within the hair growth treatment industry. Even better, today’s news involves a new drug entering a phase 1 clinical trial in the US. New Drug Candidate TDM-105795 TechnoDerma Medicines Inc. of China is an early-stage biotech company based in the Zhejiang Province of China. The…

Read More

Verteporfin Could Create Scarless Hair Transplant Surgery

May 11, 2021 /

New research from Stanford University may have uncovered a new useful application for hair restoration surgery. Stanford Stops The Engrailed-1 Last month in April, a research team from Stanford University headed by Dr. Michael Longaker, published a study on scarless wound healing which captured mainstream attention. The peer-reviewed study titled “Preventing Engrailed-1 activation in fibroblasts yields…

Read More

HaplnScience and Rise Technology: New Hair Growth Companies Q2 2021

April 20, 2021 /

In this article we will take a look at two new companies developing therapies for hair growth in 2021.  HaplnScience: Targeting The Cause Of Aging In Hair Follicles HaplnScience is a new company developing therapies for age-related diseases including androgenic alopecia, based where else, but South Korea. The company was founded in 2018 by experienced…

Read More

The Rise Of Mail Order Topical Finasteride

March 31, 2021 /

Two prominent US startups have emerged offering online consultations for prescription medicine including topical finasteride. Online Consultations For Topical Finasteride Have you ever wanted to try topical finasteride but did not quite know how to procure it? Well, you now have the opportunity. Two companies in the US, Happy Head and Strut, are now offering…

Read More

Histogen Announces 26 Week Results In Latest HST-001 Trial

February 16, 2021 /

Update: Histogen Ends HST-001 (6/3/21) Histogen has announced that it is suspending the development of HST-001 aka HSC. Their latest press release appears to mark the end of the 12 year run that the “hair stimulating complex” had in this industry. Although the diplomatic word “suspending” was used, we can be all but sure this…

Read More

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.